Histamine antagonist Bepotastine suppresses nasal symptoms caused by Japanese cedar and cypress pollen exposure [0.03%]
日本扁柏花粉引起的鼻部症状的组胺拮抗剂苯氧拉斯特的抑制作用
Sho Kanzaki,Kazuhiro Hashiguchi,Ken-Ichiro Wakabayashi et al.
Sho Kanzaki et al.
Objective: To determine the efficacy of the antihistamine bepotastine on treating nasal symptoms in patients with Japanese cedar and cypress pollinosis, based on two previous studies that looked at bepotastine OD's inhibitory effect on symp...
Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial [0.03%]
孟鲁司特治疗日本儿科患者常年性过敏性鼻炎的开放临床试验
Kimihiro Okubo,Yoichi Inoue,Hirotaka Numaguchi et al.
Kimihiro Okubo et al.
Background: This study was conducted to evaluate the safety and tolerability, and population pharmacokinetics (PPK) of montelukast as well as efficacy in the treatment of perennial allergic rhinitis (PAR) in paediatric Japanese patients age...
Comparison of the action of diclofenac alone versus diclofenac plus B vitamins on mobility in patients with low back pain [0.03%]
单独使用双氯芬酸或联合使用多种维生素B与双氯芬酸对治疗慢性下腰痛患者活动能力的影响比较研究
Mauro Geller,Marco Antonio Mibielli,Carlos Pereira Nunes et al.
Mauro Geller et al.
Objective: To assess results of the finger-to-floor distance (FFD) and the Schober test performed during the DOLOR study, and to verify correlation between Visual Analog Pain Scale scores (VAS) with these measures. Research design and metho...
Vasilios G Athyros,Niki Katsiki,Asterios Karagiannis
Vasilios G Athyros
Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers [0.03%]
五种度他雄胺胶囊(每种0.1毫克)与单剂0.5毫克度他雄胺胶囊生物等效性评价：健康男性受试者中的随机试验
Michael J Fossler,David A Collins,Hiroko Ino et al.
Michael J Fossler et al.
Objective: To evaluate the bioequivalence of five 0.1 mg dutasteride capsules to one 0.5 mg dutasteride capsule in healthy adult male subjects under fasting conditions. ...
Occurrence of drug-drug interactions in Adama Referral Hospital, Adama city, Ethiopia [0.03%]
埃塞俄比亚阿达玛转诊医院的药物相互作用发生率
Thirumurugan Gunasekaran,Natsanet Dejene,Vanapalli V Satyaveni et al.
Thirumurugan Gunasekaran et al.
Objective: Many medications have potential interactions with other drugs or substances when prescribed together. This study was intended to investigate the extent of poly-pharmacy, event of drug-drug interactions and asso...
Preparation and clinical evaluation of Finastride gel in the treatment of idiopathic Hirsutism [0.03%]
芬asteride凝胶治疗特发性多毛症的临床前研究和临床评价
Reza Tahvilian,Ali Ebrahimi,Omid Beiki et al.
Reza Tahvilian et al.
Objective: Hirsutism is the presence of excess terminal hairs in females in a male-like pattern. The most accepted hypothesis for the development of hirsutism is increased 5α-reductase activity in hair follicles of hirsu...
Rashid Kazerooni,Jane Lim
Rashid Kazerooni
Background: Cardiovascular diseases are among the leading causes of death worldwide and studies have found a direct relationship between levels of low-density lipoprotein cholesterol and coronary heart disease. Statins ar...
Results of sustained long-term use of interferon beta-1a in a community-based cohort of patients with relapsing multiple sclerosis [0.03%]
干扰素β-1a治疗复发性多发性硬化症的长期疗效：基于社区患者的队列研究结果
Stanley Cohan,Chiayi Chen,Elizabeth Baraban et al.
Stanley Cohan et al.
Background: Few studies have evaluated long-term efficacy of interferon beta-1a in large community-based cohorts. Objective: Evaluate t...
Placebo-controlled study with OHIO chamber of prophylactic pranlukast for children with Japanese cedar pollinosis: TOPIC-J III study [0.03%]
日本柏树花粉症儿童预防用普拉鲁卡斯(OHIO室研究)的安慰剂对照试验：TOPIC-J III试验
Kei Hosoya,Satoru Masuno,Kazuhiro Hashiguchi et al.
Kei Hosoya et al.
Objective: This double-blind, placebo-controlled comparative study was designed to investigate whether pranlukast dry syrup, a leukotriene receptor antagonist, has a protective effect against priming, controlled pollen ex...